Laserfiche WebLink
STM 2023-1 APPROPRIATION CONMTTEE 31 OCTOBER 2023 <br /> The second proposed adjustment updates the debt service appropriations made for the water and wastewater funds. <br /> The appropriations at the 2023 ATM were based on estimates of the debt service to be incurred in FY2024. The <br /> revised appropriations reflect the actual amounts finalized subsequent to the ATM. <br /> Line From To Change <br /> 3600 Water Fund Debt Service $ 2,393,902 $ 2,375,660 $ (18,242) <br /> 3700 Wastewater Fund Debt Service $ 1,492,248 $ 1,406,381 $ (85,867) <br /> Article 5 Appropriate for Authorized Capital Improvements <br /> Funds Requested Funding Source Committee Recommendation <br /> None N/A IP (8-0) <br /> As of publication, there are no requests for supplemental appropriations for previously approved capital projects. <br /> No action is required under this article. <br /> Article 6 Appropriate Opioid Settlement <br /> Funds Requested Funding Source Committee Recommendation <br /> $187,927 Statewide Opioid Settlement Approve (8-0) <br /> This article seeks to appropriate $187,927 recently received from the State into the Opioid Settlement Account, an <br /> account created last year and maintained in the General Fund. The funds represent Lexington's share of this year's <br /> installment of settlement payments made to the Commonwealth of Massachusetts under the Statewide Opioid <br /> Settlements entered into between the Massachusetts Attorney General and certain non-bankrupt opioid industry <br /> participants in 2021 (the "2021 Settlements"). The 2021 Settlements provided approximately $500 million to the <br /> Commonwealth, and the funds began flowing in June of 2022.1 <br /> Under the 2021 Settlements, Lexington and certain other Massachusetts communities which elected to participate <br /> are entitled to receive annual payments over eighteen years (2021-2038) from two sources: opioid manufacturer <br /> Johnson & Johnson, and several settling distributors. The total amount that Lexington will receive over the life of <br /> the 2021 Settlements is approximately $1,000,000 (not discounted to present value). The settling defendants have <br /> received, in exchange, a general release of all further claims. <br /> The 2021 Settlements contain strict requirements for the Town's handling and use of settlement funds. The <br /> payments must be appropriated into the General Fund and may only be used to fund opioid prevention, harm <br /> reduction, treatment and recovery programs. Once appropriated, the funds will be available for spending for the <br /> stated purposes at the discretion of Lexington's Director of Public Health. <br /> It should be noted that three additional nationwide opioid settlements were entered into between the states and other <br /> members of the industry in 2022 (the "2022 Settlements"). Under the 2022 Settlements: (1) distributor Walmart <br /> will provide $61 million to the Commonwealth; (2) manufacturers Teva and Allergan will provide $130 million to <br /> the Commonwealth; and(3) distributors CVS and Walgreen's will provide $230 million to the Commonwealth. The <br /> State will then, once again, share the settlement amounts with participating municipalities. Lexington has yet to <br /> receive funds under the 2022 Settlements. <br /> 1 For further details, see the Attorney General's statement online: <br /> https://www.mass.gov/info-details/learn-about-the-ags-statewide-opioid-settlements-with-opioid- <br /> industry-defendants <br /> 5 <br />